Douglas Yee, MD | Authors

Articles

Phase II ADAPT Trial in Patients With HER2+ and HR+ Early Breast Cancer

July 31, 2015

Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical oncologist, University of Minnesota, discusses the results of the phase II ADAPT trial.